US Patent No. 9,399,765

Construction of new variants of dextransucrase DSR-S by genetic engineering
Jul 28, 2016

Centre National de la Recherche Scientifique, Institut National de Recherche Scientifique, and Institut National des Sciences Appliquees de TouLouse have been awarded US Patent No. 9,399,765, "Construction of new variants of dextransucrase DSR-S by genetic engineering."

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.